UK government announces life sciences deal; GSK and AstraZeneca invest

11-12-2017

The UK government has announced a deal between the life sciences sector and the government, aimed at ensuring that the “next wave of breakthrough treatments” and innovative medical research and technologies are created in the country.


UK government, life sciences, industrial strategy, GSK, innovation, research, AstraZeneca

LSIPR